Skip to: Curated Story Group 1
healthcarebusinessreview

Advertise

with us

    • US
    • EUROPE
    • APAC
    • CANADA
  • Home
  • Sections
    Business Process Outsourcing
    Compliance & Risk Management
    Consulting Services
    Dental Billing Services
    Facility Management Services
    Financial Services
    Health Insurance
    Healthcare Education
    Healthcare Marketing
    Healthcare Procurement
    Healthcare Security
    Healthcare Staffing
    Medical Billing
    Medical Case Management
    Medical Transportation
    Multi Speciality
    Pathology Services
    Patient Monitoring
    Pharmacy Service
    Practice Management Services
    Real Estate Services
    Supply Chain
    Telemedicine Services
    Therapy Services
  • CXO Insights
  • News
  • Vendor Viewpoint
  • Conferences
  • CXO Awards
8 MARCH 2026IN MY OPINIONSSIs Are Not Minor Short-term Problems, They're Major Long-term BurdensBy Gianluca Casali, Medical Director, UK and Ireland JnJ Medical Devices, Johnson & JohnsonDuring the entirety of my medical career, rarely have I come across a healthcare burden as grossly underestimated as surgical site infections (SSIs). They're often thought of as an acute events with minimal impact on the long-term quality of a patient's life, on mortality and on cost. Unfortunately, this is not true. SSIs are not simply a minor problem that can be easily treated with antibiotics and therefore cause only a minor delay in the recovery process. In fact, they can have a detrimental impact on long-term survival, morbidity rates, and financial burden on healthcare systems.Recent evidence collected in different countries and for different pathologies suggests that even SSIs that are treated effectively can have a detrimental impact on long-term survival. A Canadian study looked at over 14,000 patients between 2010 and 2015 and revealed Gianluca Casali
< Page 7 | Page 9 >